T1	PROC 47 62	estudio clínico
#1	AnnotatorNotes T1	C0008972; Clinical Research; Research Activity | C0008976; Clinical Trials; Research Activity
T2	LIVB 68 77	pacientes
#2	AnnotatorNotes T2	C0030705; Patients; Patient or Disabled Group
T3	PROC 78 92	diagnosticados
#3	AnnotatorNotes T3	C0011900; Diagnosis; Diagnostic Procedure
T4	DISO 97 127	Esclerosis Lateral Amiotrófica
#4	AnnotatorNotes T4	C0002736; Amyotrophic Lateral Sclerosis; Disease or Syndrome
T5	DISO 129 132	ELA
#5	AnnotatorNotes T5	C0002736; Amyotrophic Lateral Sclerosis; Disease or Syndrome
T6	PROC 165 180	estudio clínico
#6	AnnotatorNotes T6	C0008972; Clinical Research; Research Activity | C0008976; Clinical Trials; Research Activity
T7	PROC 211 247	Estudio de fase 3, extensión abierta
T8	DISO 305 308	ELA
#7	AnnotatorNotes T8	C0002736; Amyotrophic Lateral Sclerosis; Disease or Syndrome
T9	DISO 332 356	enfermedad de Lou Gehrig
#8	AnnotatorNotes T9	C0002736; Amyotrophic Lateral Sclerosis; Disease or Syndrome
T10	DISO 359 393	enfermedad de las neuronas motoras
#9	AnnotatorNotes T10	C0085084; Motor Neuron Disease; Disease or Syndrome
T11	DISO 402 438	degeneración progresiva y mortal del
T12	ANAT 439 455	sistema nervioso
#10	AnnotatorNotes T12	C0027763; Nervous system structure; Body System | C1269560; Entire nervous system; Body System
T13	DISO 482 512	Esclerosis Lateral Amiotrófica
#11	AnnotatorNotes T13	C0002736; Amyotrophic Lateral Sclerosis; Disease or Syndrome
T14	DISO 514 517	ELA
#12	AnnotatorNotes T14	C0002736; Amyotrophic Lateral Sclerosis; Disease or Syndrome
T15	PHYS 555 565	comprender
T16	PROC 603 627	Consentimiento Informado
#13	AnnotatorNotes T16	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T17	LIVB 635 643	paciente
#14	AnnotatorNotes T17	C0030705; Patients; Patient or Disabled Group
T18	PHYS 656 666	comprender
T19	PROC 682 707	consentimiento no escrito
T20	Neg_cue 697 699	no
T21	Negated 700 707	escrito
T22	LIVB 712 719	testigo
#15	AnnotatorNotes T22	C0009932; Control Groups; Group | C0682356; Witnesses; Population Group
T23	LIVB 734 742	paciente
#16	AnnotatorNotes T23	C0030705; Patients; Patient or Disabled Group
T24	PROC 771 795	Consentimiento Informado
#17	AnnotatorNotes T24	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T25	CHEM 874 909	fármaco de estudio en investigación
T26	CHEM 923 934	reldesemtiv
T27	PROC 948 962	administración
#18	AnnotatorNotes T27	C1533734; Administration procedure; Therapeutic or Preventive Procedure
T28	Duration 974 981	30 días
T29	Duration 984 999	cinco semividas
T30	CHEM 1004 1010	agente
#19	AnnotatorNotes T30	C0450442; Agent; Chemical Viewed Functionally
